NN3201

NN3201 · Novelty Nobility, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NN3201, covering 2025-09-23 to 2025-09-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit [Phase 1]

See pricing